U.S. markets closed

Voya Emerging Markets High Dividend Equity Fund (IHD)

NYSE - Nasdaq Real Time Price. Currency in USD
Add to watchlist
5.79+0.09 (+1.58%)
At close: 04:00PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bearishpattern detected
Commodity Channel Index

Commodity Channel Index

Previous Close5.70
Bid3.30 x 800
Ask6.83 x 1000
Day's Range5.80 - 5.85
52 Week Range5.60 - 8.68
Avg. Volume72,180
Market Cap109.671M
Beta (5Y Monthly)N/A
PE Ratio (TTM)N/A
Earnings DateN/A
Forward Dividend & Yield0.72 (12.48%)
Ex-Dividend DateApr 02, 2018
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value

Subscribe to Yahoo Finance Plus to view Fair Value for IHD

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Voya Emerging Markets High Inco
    SEIC: Lowering target price to $60.00SEI INVESTMENTS COMPANY has an Investment Rating of HOLD; a target price of $60.000000; an Industry Subrating of High; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Medium; a Growth Subrating of Medium; and a Value Subrating of Medium.
    Fair Value
    Economic Moat
    4 months agoArgus Research
View more
  • Business Wire

    Voya Equity Closed End Funds Declare Distributions

    SCOTTSDALE, Ariz., June 15, 2022--Voya Investment Management, the asset management business of Voya Financial, Inc. (NYSE: VOYA), announced today the distributions on the common shares of three of its closed-end funds (each a "Fund" and collectively, the "Funds").

  • GlobeNewswire

    Vaxart Appoints Edward Berg as Senior Vice President and General Counsel

    Pharmaceutical Industry Veteran Brings Broad Legal Expertise to Vaxart Senior Management Team SOUTH SAN FRANCISCO, Calif., Feb. 14, 2022 (GLOBE NEWSWIRE) -- Vaxart, Inc. (NASDAQ: VXRT) today announced the appointment of Edward B. Berg as the Company's first in-house General Counsel, effective today. Mr. Berg has practiced law for more than 30 years and has represented Fortune 500 and mid-cap companies in biotechnology, pharmaceuticals and life sciences. He joins Vaxart from BioMarin Pharmaceutic

  • GlobeNewswire

    Vaxart Announces Acquisition of Second GMP Manufacturing Facility

    Purchase expected to give Vaxart greater control over manufacturing schedulesSOUTH SAN FRANCISCO, Calif., Dec. 01, 2021 (GLOBE NEWSWIRE) -- Vaxart, Inc. (NASDAQ: VXRT) has entered into an agreement with Kindred Bioscience, Inc. (“KindredBio”) for the purchase of KindredBio’s manufacturing equipment and sublease of its GMP (Good Manufacturing Practices) manufacturing facility in Burlingame, California, giving Vaxart control of its second GMP manufacturing facility. The transaction closed Tuesday,